DRUG

Bright Minds BiosciencesB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-06-02

View Chart

Peers tracked

U.S. public peers

Grade Position

In line

vs peer average

DRUG vs peer average

54/100

DRUG vs. peer average (B vs. B)

Grade spread

A 3 · B 1 · C 3 · D 1

Graded peers loaded

Coverage

10 graded

100% of tracked

Peer overview

ACAD is the first available peer comparator.

CNS-focused developer with similar regulatory and commercial execution risks; useful comparator for readout-driven re-ratings.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerACADACADIA

DRUG

Bright Minds Biosciences

ACAD

ACADIA

Grade

Momentum

Value

Sentiment

Setup Bias

Net Neutral

Market Cap

Posture

Constructive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs ACAD

DRUG / ACAD

Grade Position

In line

DRUG vs. peer average (B vs. B)

54/100

Momentum

DRUG

Value

ACAD

Sentiment

DRUG

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs DRUG

ACAD

60/100

IONQ

60/100

VOR

Vor Biopharma Inc Common

40/100

EVMN

Evommune Inc Common

N/A

ETON

Eton Pharmaceuticals Inc Common

100/100

-1

ACAD is the first peer returned for this comparison set.